# Ruxience

NDC: 0069-0238
Generic name: rituximab-pvvr
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200123

FDA application: BLA761103

## Active ingredients

- RITUXIMAB: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0238"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0238
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f941fc61-f7a3-4e4a-ab7c-87c1667fa05b